Alcobra Ltd.
(NASDAQ : ADHD)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ADHD News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.06%10.759.9%$297.33m
PRGOPerrigo Co. Plc
-0.29%67.964.8%$179.65m
SHPGShire PLC Sponsored ADR
0.70%175.230.3%$161.46m
MDCOMedicines Company
1.40%50.6922.6%$134.46m
ENDPEndo International Plc
-0.20%9.978.9%$131.03m
JAZZJazz Pharmaceuticals Plc
0.45%143.141.9%$89.29m
MNKMallinckrodt Plc
-0.21%43.0912.8%$86.79m
UTHRUnited Therapeutics Corporation
0.66%140.0511.5%$85.74m
PRXLPAREXEL International Corporation
0.86%62.356.7%$70.21m
PCRXPacira Pharmaceuticals, Inc.
-0.11%46.9016.9%$67.17m
PTLAPortola Pharmaceuticals, Inc.
0.55%38.4410.3%$48.48m
ICPTIntercept Pharmaceuticals, Inc.
0.80%116.7322.8%$45.29m
HZNPHorizon Pharma plc
-1.31%14.379.7%$45.07m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.04%121.179.9%$39.39m
ICLRICON Plc
1.73%78.942.8%$38.72m

Company Profile

Alcobra Ltd. engages in the research, development, and market of pharmaceutical productsfor the treatment of central nervous system disorders and cognitive dysfunctions. Its portfolio includes Metadoxine Extended Release to treat Attention Deficit Hyperactivity Disorder and Fragile X Syndrome. The company was founded by Ehud Moshe Gilboa and Dalia Megiddo on February 7, 2008 and is headquartered in Tel Aviv, Israel.